mSWI/SNF Component ARID1A Mediates Breast Cancer Treatment Response
- PMID: 31953241
- DOI: 10.1158/2159-8290.CD-RW2020-011
mSWI/SNF Component ARID1A Mediates Breast Cancer Treatment Response
Abstract
ARID1A is required for response of ER+ breast cancer cells to tamoxifen and fulvestrant but not JQ1.
©2020 American Association for Cancer Research.
Comment on
-
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.Nat Genet. 2020 Feb;52(2):187-197. doi: 10.1038/s41588-019-0541-5. Epub 2020 Jan 6. Nat Genet. 2020. PMID: 31913353 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous